Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-03-22 11:13 am Sale | 13D | Sesen Bio, Inc. SESN | HealthCap VII L.P. | 3,398,248 8.4% | -181,363 (-5.07%) | View |
| 2023-03-09 10:33 am Purchase | 13D | Sesen Bio, Inc. SESN | HealthCap VII L.P. | 3,579,611 8.9% | 3,579,611 (New Position) | View |
| 2023-03-06 4:06 pm Unchanged | 13D | Fusion Pharmaceuticals Inc. FUSN | HealthCap VII L.P. | 3,807,247 6.1% | 0 (Unchanged) | View |
| 2022-11-15 5:08 pm Unchanged | 13D | Aprea Therapeutics, Inc. APRE | HealthCap VII L.P. | 2,366,104 4.5% | 0 (Unchanged) | View |
| 2022-06-30 4:34 pm Unchanged | 13D | Aprea Therapeutics, Inc. APRE | HealthCap VII L.P. | 2,366,104 10.1% | 0 (Unchanged) | View |
| 2021-10-15 4:50 pm Unchanged | 13D | Aprea Therapeutics, Inc. APRE | HealthCap VII L.P. | 2,366,104 11.2% | 0 (Unchanged) | View |
| 2020-07-10 5:00 pm Purchase | 13D | Fusion Pharmaceuticals Inc. FUSN | HealthCap VII L.P. | 3,807,247 9.1% | 3,807,247 (New Position) | View |
| 2019-10-18 09:22 am Purchase | 13D | Aprea Therapeutics, Inc. APRE | HealthCap VII L.P. | 2,366,104 11.9% | 2,366,104 (New Position) | View |